Cocaine concentrations in fetal C57BL/6 mouse brain relative to maternal brain and plasma

Neurotoxicology and Teratology

Volumn 18, Issue 6, 1996, Pages 645-649

  Miller, Scott R ^a   Middaugh, Lawrence D ^b   Boggan, William O ^b   Patrick, Kennerly S ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NONE   (United States)

Author keywords

brain; C57BL 6 mouse; cocaine; fetus; plasma; pregnancy

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; FETUS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ANIMALS; BRAIN; COCAINE; DEUTERIUM; FEMALE; FETAL BLOOD; HUMANS; INJECTIONS, SUBCUTANEOUS; MATERNAL-FETAL EXCHANGE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; PREGNANCY; REGRESSION ANALYSIS; TIME FACTORS;

ANIMALIA;

EID: 0030293726     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(96)00076-1     Document Type: Article

References (37)

1. Bateman, D. A.; Ng, S. K. C.; Hansen, C. A.; Heagarty, M. C. The effects of intrauterine cocaine exposure in newborns. Am. J. Public Health 83:190-193; 1993.
2. Benuck, M.; Lajtha, A.: Reith, M. E. A. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:144-149; 1987.
3. Chasnoff, I. J.; Lewis, D. E.; Griffith, D. R.; Willey. J. Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clin. Chem. 35:1276-1278; 1989.
4. Chiou, W. L. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics. Clin. Pharmacokinet. 17:175-199; 1989.
5. Devane, C. L.; Simpkins, J. W.; Miller, R. L.; Braun, S. B. Tissue distribution of cocaine in the pregnant rat. Life Sci. 45:1271-1276; 1989.
6. Dixon, S. D.; Bejar, R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J. Pediatr. 115:770-778; 1989.
7. Dow-Edwards, D. L.; Freed, L. A.; Milhorat, T. H. Simulation of brain metabolism by perinatal cocaine exposure. Dev. Brain Res. 42:137-141; 1988.
8. Dow-Edwards, D. L. Developmental effects of cocaine, NIDA Res. Monogr., 88:290-303: 1988.
9. Dow-Edwards, D. Fetal and maternal cocaine levels peak rapidly following intragastric administration in the rat. J. Subst. Abuse 2:427-437; 1990.
10. Dow-Edwards, D. L.; Freed. L. A.: Fico, J. A. Structural and functional effects of prenatal cocaine exposure in adult rat brain. Dev. Brain Res. 57:263-268; 1990.
11. Finnegen, L. P.; Mellott, J. M.; Williams, L. R.; Wapner, R. J. Perinatal exposure to cocaine: human studies. In: Lakoski, J. M.; Galloway, M. P.; White, F. J., eds. Cocaine pharmacology, physi-ology, and clinical strategies. Boca Raton, FL: CRC Press; 1992:391-409.
12. Hatchings, D. E. The puzzle of cocaine's effects following maternal use during pregnancy: Are there reconcilable differences? Neurotoxicol. Teratol. 15:281-286; 1993.
13. Javaid, J. I.; Davis, J. M. Cocaine disposition in discrete regions of rat brain. Biopharm. Drug Dispos. 14:357-364; 1993.
14. Lau, C. E.; Iman, A.; Ma, F.; Falk. J. L. Acute effects of cocaine on spontaneous and discriminative motor functions: Relation to route of administration and pharmacokinetics. J. Pharmacol. Exp. Ther. 257:444-456; 1991.
15. Levine, S. R.; Washington, J. M.; Jefferson, M. F.; Kieran, S. N.; Moen, M.; Feit, H.; Welsh, K. M. A. "Crack" cocaine-associated stroke. Neurology 37:1849-1853; 1987.
16. Mahalik, M. P.; Gautieri, R. F.; Mann, D. E., Jr. Mechanisms of cocaine-induced teratogenesis. Res. Commun. Subst. Abuse 5:279-302; 1984.
17. Middaugh, L. D.; Boggan, W. O. Postnatal growth deficits in prenatal ethanol exposed mice: Characteristics and critical periods. Alcohol. Clin. Exp. Res. 15:919-926; 1991.
18. 3H]-cocaine in rat brain. Experientia 30:1312-1314; 1974.
19. Morishima, H. O.; Cooper, T. B.; Hara,T.; Miller, E. D., Jr. Pregnancy alters the hemodynamic responses to cocaine in the rat. Dev. Pharmacol. Ther. 19:69-79; 1992.
20. 3H]cocaine in acutely and chronically treated rats. J. Pharmacol. Exp. Ther. 196:556-569; 1976.
21. Needleman, R.; Zuckerman, B.; Anderson, G. M.; Mirochnick, M.; Cohen, D. J. Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: A preliminary study. Pediatrics 92:55-60; 1993.
22. Pan. H. T.; Menacherry, S.: Justice, Jr., J. B.. Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J. Neurochem. 56:1299-1306; 1991.
23. Patrick, K. S.; Boggan, W. O.; Miller, S. R.; Middaugh, L. D. Gas chromatographic-mass spectrometric determination of plasma and brain cocaine in mice. J. Chromatogr. B Biomed. Appl. 621:89-94; 1993.
24. Patrick, K. S.; Ellington, K. R.; Breese, G. R. Distribution of methylphenidate and p-hydroxymethylphenidate in rats. J. Pharmacol. Exp. Ther. 231:61-65; 1984.
25. Reith, M. E. A.: Benuck, M.; Lajtha, A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:281-287: 1987.
26. Ritscef. W. A.; Adolph, S.; Denson, D. D. Ion-trapping of meperidine: Influence of antacid treatments on serum and gastric fluid concentrations. Methods Find. Exp. Clin. Pharmacol. 12:47-51; 1990.
27. Roberts. S. M.; Phillips, D. L.: Tebbett, I. R. Increased blood and brain cocaine concentrations with ethanol cotreatment in mice. Drug Metab. Disp. 23:664-666; 1995.
28. Sandberg, J. A.; Olsen, G. D. Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration. J. Pharmacol. Exp. Ther. 260:587-591; 1991.
29. Shah, N. S.: May. D. A.; Yates, J. D. Disposition of levo[3H]cocaine in pregnant and nonpregnant mice. Toxicol. Appl. Pharmacol. 53:279-284; 1980.
30. Shore, P. A.; Brodie, B. B.; Hogben, C. A. M. The gastric secretion of drugs: A pH partition hypothesis. J. Pharmacol. Exp. Ther. 119:361-369:1956.
31. Spear, L. P.: Frambes, N. A.; Kirstein. C. L. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic SC administration of cocaine during gestation in rats. Psychopharmacology (Berlin) 97:427-431; 1989.
32. Spear. L. P.; Kirstein, C. L.; Frambes, N. A. Cocaine effects on the developing CNS: Behavioral, psychopharmacological and neurochemical studies. Ann. NY Acad. Sei. 562:290-307; 1989.
33. Stoeckel. H.; Hengstmann, J. H.; Schuttler. J. Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. Br. J. Anaesth. 51:741-5: 1979.
34. Weiner, L. H.; Reith, M. E. A. Correlation between cocaineinduced locomotion and cocaine disposition in the brain among four inbred strains of mice. Pharmacol. Biochem. Behav. 36:699701; 1990.
35. Wiggins, R. C.; Rolsten. C.; Rutz. B.; Davis, C. M. Pharmacokinetics of cocaine: Basic studies of route, dosage, pregnancy and lactation. Neurotoxicology 10:367-382; 1989.
36. Woods, J. R.; Plessinger, M. A.: Clark, K. E. Effect of cocaine on uterine blood flow and fetal oxygenation. J. Am. Med. Assoc. 257:957-961: 1987.
37. Zachor, D.: Cherkes, J. K.; Fay. C. T.; Ocrant, I. Cocaine differentially inhibits neuronal differentiation and proliferation in vivo. J. Clin' Invest. 93:1179-1185; 1994.